Author： III Thomas Q Garvey Hyman Paul E
Publisher： Informa Healthcare
ISSN： 1474-0338
Source： Expert Opinion on Drug Safety, Vol.1, Iss.1, 2002-05, pp. : 1-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Barman Balfour J.A. Goa K.L. Perry C.M.
Drugs, Vol. 59, Iss. 3, 2000-03 ,pp. :
Access to resources
Recommend
Alosetron reintroduction debated
Inpharma, Vol. 1, Iss. 1356, 2002-01 ,pp. :
Alosetron and irritable bowel syndrome
By Mayer Emeran A Bradesi Sylvie
Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 11, 2003-11 ,pp. :
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 308, 2001-01 ,pp. :
Alosetron: A Viewpoint by Douglas A. Drossman
Drugs, Vol. 59, Iss. 3, 2000-03 ,pp. :